Nilotinib hydrochloride monohydrate
| Nilotinib hydrochloride monohydrate | |
|---|---|
| Term | Nilotinib hydrochloride monohydrate |
| Short definition | Nilandron - (pronounced) (nih-LAN-drun) drug used to treat prostate cancer that has spread to other parts of the body. It is used in patients who have had an operation (orchiectomy) on their testicles. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
Nilotinib hydrochloride monohydrate - (pronounced) (ny-LOH-tih-nib HY-droh-KLOR-ide MAH-noh-HY-drayt) A drug used to treat certain types of chronic myeloid leukemia that are Philadelphia chromosome positive. It is also being studied in the treatment of other types of cancer. Nilotinib hydrochloride monohydrate blocks BCR-ABL and other proteins that may help prevent cancer cells from growing. It's a type of tyrosine kinase inhibitor. Also called Tasigna
External links
- Medical encyclopedia article on Nilotinib hydrochloride monohydrate
- Wikipedia's article - Nilotinib hydrochloride monohydrate
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski